Bigul

Strides Pharma Science Ltd - 532531 - Re-Appointment Of M/S. B S R & Co. LLP, Chartered Accountants As Statutory Auditors Of The Company - Disclosure Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

We wish to inform you that at the 31st Annual General Meeting ('AGM') of the Company held on September 9, 2022, Shareholders of the Company have approved the re-appointment of M/s. B S R & Co. LLP, Chartered Accountants (ICAI Firm Registration no. 101248W/W-100022) as Statutory Auditors of the Company for a second term of 5 (five) consecutive years. The details of re-appointment of auditors as required under SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 including a brief profile of the auditors, is enclosed as Annexure A to this letter. This is for your information and records.
10-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Outcome of the 31st Annual General Meeting of the Company
10-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of the 31st Annual General Meeting of the Company
10-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Proceedings Of The 31St Annual General Meeting (AGM) Of The Company

We wish to inform you that the 31st AGM of the Company was held on Friday, September 9, 2022 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the AGM. This is for your information and records.
09-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment

Allotment of 1,50,830 equity shares of face value of Rs. 10/- each to M/s. Karuna Business Solutions LLP (Warrant Holder) upon conversion of equivalent number of warrants to equity shares.
08-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment

The Management Committee of the Board of Directors of the Company in their meeting held today have allotted the following: 1) 34,000 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan; and; 2) 1,50,830 equity shares of face value of Rs. 10/- each to M/s. Karuna Business Solutions LLP (Warrant Holder), upon conversion of equivalent number of warrants to equity shares
02-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Stelis Biopharma's flagship facility receives USFDA nod for Drug Product Capabilities
01-09-2022
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation pursuant to Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
30-08-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science has informed the Exchange about press release issued by Universal Corporation Limited, a Strides Pharma Science Enterprise, titled First African-manufactured medicine to prevent malaria in pregnant women and infants quality - approved by WHO
26-08-2022
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

This has reference to our intimation letter dated August 18, 2022, relating to Notice of the 31st Annual General Meeting of the Company. In compliance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements confirming completion of dispatch of notices to the eligible members of the Company as published in Business Standard (English - All Edition) and in Navashakthi (Marathi Edition). This is for your information and records.
19-08-2022
Next Page
Close

Let's Open Free Demat Account